arrow
S

Sandra B. Gabelli

Sidney Kimmel Comprehensive Cancer Center
H指数:40
被引数:7,767

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements

双特异性抗体和靶向TP53突变相关新抗原的CAR T细胞显示出不同的亲和力需求

2026-01-160
OA
WRN structural flexibility showcased through fragment-based lead discovery of inhibitors

WRN结构柔韧性通过基于片段的先导化合物发现抑制剂得到展示

2026-01-030
OAAI
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
2024-07-101
PRE
Cancer therapy with antibodies

用抗体治疗癌症

2024-05-1314
PRE
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

用于治疗T细胞癌症的TRBC1-targeting抗体-药物结合物

Nature
IF48.5
2024-03-270
PRE
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen

疏水相互作用主导了KRAS G12V新抗原的识别

2023-08-218
OAAI
Hybrid TCR-CAR design surpasses conventional CARs and patient-derived TCRs in targeting an ultra-low-density neoantigen
2023-04-140
PRE
The rapid and highly parallel identification of antibodies with defined biological activities by SLISY

通过slissy快速,高度平行地鉴定具有确定生物学活性的抗体

2023-01-031
OAAI